Bharat Biotech seeks full marketing approval from DCGI for its Covid vaccine Covaxin

In an application sent to the Drugs Controller General of India (DCGI) this week, V Krishna Mohan, Whole-Time Director at the Hyderabad-based company submitted complete information regarding chemistry, manufacturing and controls, along with pre-clinical and clinical data while seeking regular market authorisation for Covaxin.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33qjbgR
via IFTTT